A kind of aureomycin premix for veterinary use and preparation method thereof
A premix and chlortetracycline technology, applied in the field of feed additives, can solve the problems of antibiotic resistance, increased costs and risks, and achieve the effects of promoting absorption, improving bioavailability, and reducing energy consumption
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0028] Preparation of experimental example 1 chitosan-EDTA complex
[0029]
[0030]
[0031] Preparation method: Take chitosan, add 1% glacial acetic acid solution 6 times the weight of chitosan and stir until completely dissolved, then add EDTA-2Na and stir evenly, use sodium hydroxide solution to adjust pH to 5, add condensing agent 1-B Base-(3-dimethylaminopropyl) carbodiimide hydrochloride, the concentration of the condensing agent in the reaction system is 30mmol / L, after stirring at room temperature for 4h, carry out deionized water dialysis to obtain the product, freeze the product Just do it.
[0032] The chitosan-EDTA complex freeze-dried powder prepared by A-E group was carried out to measure the degree of substitution, and the results are shown in the following table:
[0033] group
[0034] It can be seen from the above table that chitosan: EDTA-2Na undergoes amidation condensation reaction at a weight ratio of 1:2, and the resulting chitosan-EDTA...
Embodiment 2
[0036] Embodiment 2 of the present invention veterinary chlortetracycline premix comprises the following raw materials in parts by weight: 25 parts of chlortetracycline hydrochloride, 35 parts of N-trimethyl chitosan, 30 parts of starch, 4 parts of povidone K30, Chitosan-EDTA complex 2 parts and water 14 parts
[0037] Preparation:
[0038] (1) Get povidone K30, add water and stir evenly to obtain povidone K30 solution for subsequent use;
[0039] (2) get aureomycin hydrochloride, N-trimethyl chitosan, starch, chitosan-EDTA compound and mix uniformly, add the povidone K30 solution of step (1) gained, stir and make soft material;
[0040] (3) Extrude the soft material obtained in step (2) through a 30-mesh sieve twice, and then through a 50-mesh sieve once to prepare granules, and dry at 45°C until the water content is <3% to obtain the premix .
Embodiment 3
[0042] Embodiment 3 of the present invention veterinary chlortetracycline premix comprises the following raw materials in parts by weight: 20 parts of chlortetracycline hydrochloride, 30 parts of N-trimethyl chitosan, 20 parts of starch, 2 parts of povidone K30, Chitosan-EDTA complex 1 part and water 10 parts.
[0043] The preparation method is the same as in Example 2.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com